ClinicalTrials.gg
Not yet recruitingNCT07541105Updated Oct 15, 2026

Cancer Awareness Among Syrian Migrants

An interventional study of PMT-Based Cancer Screening Educational Intervention and PMT-Based Cancer Screening Education Program in Breast Cancer Screening, Cervical Cancer Screening and Colorectal Cancer Screening, sponsored by Toros University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Toros University · Not applicable, Interventional, and Prevention

How we know

Updated Oct 15, 2026Start date movedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to develop and evaluate a theory-based educational intervention to improve cancer screening participation among Syrian migrants in Turkey. The study will also develop a Cancer Protection Motivation Scale (CPMS) to measure individuals' motivation toward cancer screening. Using a mixed-methods design, the study will explore barriers, beliefs, and behaviors related to breast, cervical, and colorectal cancer screening. The effectiveness of the intervention will be assessed using a pretest-posttest design. The findings are expected to support culturally appropriate strategies to improve cancer screening uptake among migrant populations.

Read the detailed description

Syrian migrants face difficulties accessing cancer screening services due to limited healthcare access, language and cultural barriers, and lack of knowledge about cancer screening. However, there is a lack of practical guidance on how public health initiatives can effectively engage with priority populations, particularly migrants. This study aims to present a protocol for developing a Protection Motivation Theory (PMT)-based educational intervention and the Cancer Protection Motivation Scale, informed by an examination of migrants' and healthcare professionals' perspectives on cancer screening. A mixed-methods study protocol has been developed to create a Protection Motivation Theory (PMT)-based educational intervention and the Cancer Protection Motivation Scale. The study will engage migrants and healthcare professionals to explore knowledge, attitudes, behaviors, and barriers related to breast, cervical, and colorectal cancer screening. In the qualitative phase, interviews will be conducted with 30 migrants and healthcare professionals, while in the methodological phase, data from 300 migrants will be used to develop and validate the scale and educational intervention. In the experimental phase, the effectiveness of the intervention will be tested with 30 participants. The study is expected to yield a valid and reliable Cancer Protection Motivation Scale and a culturally sensitive, theory-driven educational intervention. These tools will provide guidance for improving cancer awareness and screening behaviors among migrants, addressing barriers related to access, language, culture, and knowledge.

02

Conditions studied

  • Breast Cancer Screening
  • Cervical Cancer Screening
  • Colorectal Cancer Screening
  • Cancer Prevention Behavior

Keywords

  • Breast cancer
  • Colon cancer
  • Cervical cancer
  • Protection motivation
  • Reduced inequalities
03

In context

Breast Neoplasms

14,855 studies on the registry are indexed under Breast Neoplasms; 3,321 are open to participants now.

This study's planned enrollment of 30 is below the median of 72 across 10,921 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Toros University is the lead sponsor of 21 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • over 18 years of age
  • hold Syrian citizenship
  • be registered with the Migrant Health Center in Mersin province
  • have proficiency in Turkish or Arabic
  • voluntarily agree to participate

Exclusion criteria

Exclusion Criteria:

  • if they hold Turkish citizenship
  • have a diagnosed psychiatric disorder
  • have been diagnosed with cancer
  • wish to withdraw from the study
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    The group receiving the PMT-based cancer screening educational intervention.

    A Protection Motivation Theory (PMT)-based educational program focusing on breast, cervical, and colorectal cancer screening will be delivered to participants. Pretest and posttest assessments will be conducted using the Cancer Protection Motivation Scale (CPMS) to evaluate changes in motivation and screening-related behaviors.

    Other: PMT-Based Cancer Screening Educational Intervention · Behavioral: PMT-Based Cancer Screening Education Program

Interventions

  • OtherPMT-Based Cancer Screening Educational Intervention

    This intervention is a structured educational program developed based on Protection Motivation Theory (PMT). It aims to improve cancer screening behaviors among Syrian migrants through culturally adapted educational sessions focusing on breast, cervical, and colorectal cancer screening. The intervention targets key components of PMT, including threat appraisal (perceived severity, perceived vulnerability, and rewards) and coping appraisal (self-efficacy, response efficacy, and perceived costs). Educational content is designed to increase awareness, enhance motivation, and reduce perceived barriers. Participants will receive the training through interactive sessions. The effectiveness of the intervention will be evaluated using pretest and posttest assessments with the Cancer Protection Motivation Scale (CPMS).

  • BehavioralPMT-Based Cancer Screening Education Program

    This behavioral intervention is a structured education program based on Protection Motivation Theory (PMT), designed to improve cancer screening behaviors among Syrian migrants. The program targets key PMT constructs, including perceived severity, perceived vulnerability, response efficacy, self-efficacy, and perceived barriers. It includes culturally adapted, interactive educational sessions focusing on breast, cervical, and colorectal cancer screening. The intervention aims to increase knowledge, enhance motivation, and reduce perceived barriers to screening participation. Effectiveness will be evaluated using pre- and post-intervention assessments with the Cancer Protection Motivation Scale (CPMS).

    Also known as: PMT Education Program, Cancer Screening Education Intervention

06

What researchers measure

Primary outcomes

  1. Cancer Protection Motivation Scale (CPMS)

    Cancer protection motivation will be assessed using the Cancer Protection Motivation Scale (CPMS), a researcher-developed multidimensional instrument based on Protection Motivation Theory. The scale measures threat appraisal (perceived severity, vulnerability, and rewards), coping appraisal (response efficacy and response cost), and self-efficacy. The CPMS is planned to consist of 24 items rated on a 5-point Likert scale ranging from 1 = strongly disagree to 5 = strongly agree. The total score ranges from 24 to 120, with higher scores indicating greater motivation. Content validity will be evaluated using the Content Validity Index (CVI) based on the opinions of approximately 20 experts. Following language validation, a pilot study will be conducted with 20 participants, after which the scale will be administered to 300 individuals. The CPMS will be used as a pretest and posttest to evaluate effectiveness.

    Time frame: Baseline and 1 month after the intervention

Secondary outcomes

  1. Knowledge of Cancer and Screening (Structured Questionnaire Score)

    Participants' knowledge regarding breast, cervical, and colorectal cancers and related screening programs will be assessed using a researcher-developed structured questionnaire. The questionnaire will include items on cancer risk factors, symptoms, and screening recommendations. It will be administered before the intervention (pretest) and after the educational program (posttest). Higher scores will indicate greater knowledge.

    Time frame: Baseline and 1 month after the intervention

Other outcomes

  1. Cancer Screening Behavior (Referral and Attendance Rates)

    Participants' cancer screening behaviors will be assessed by measuring referral and attendance rates to relevant health facilities for breast, cervical, and colorectal cancer screening. The number and proportion of participants who attend screening services after the intervention will be recorded. Behavioral changes will be evaluated by comparing screening attendance before and after the educational program.

    Time frame: Up to 1 month after the intervention

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2027; primary completion for Jul 2027, 4 months later.

Of 2,673 non-industry interventional studies with no phase under Breast Neoplasms, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 66. This study's planned 4 months is below that.

Counting every sponsor, half of 2,783 studies reached it within 33 months; a quarter within 15 and three quarters within 66.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 15, 2026: start Apr 2026 → Mar 2027, primary completion May 2026 → Jul 2027 and completion Jul 2026 → Jul 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 11, 2026
First posted
Apr 21, 2026
StartEst.
Mar 9, 2027was Apr 2026
Primary completionEst.
Jul 9, 2027was May 2026
CompletionEst.
Jul 9, 2027was Jul 2026
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Apr 20, 2026→Mar 9, 2027
Oct 15, 2026
Primary completion
May 15, 2026→Jul 9, 2027
Oct 15, 2026
Study completion
Jul 15, 2026→Jul 9, 2027
Oct 15, 2026
Primary outcomes
1 time frame changed
What changed in the outcomes
  • Time frameCancer Protection Motivation Scale (CPMS)3 weeks → Baseline and 1 month after the intervention
Oct 15, 2026
Secondary outcomes
2 time frame changed
What changed in the outcomes
  • Time frameKnowledge of Cancer and Screening (Structured Questionnaire Score)3 weeks → Baseline and 1 month after the intervention
  • Time frameother outcomeCancer Screening Behavior (Referral and Attendance Rates)3 weeks → Up to 1 month after the intervention
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    Start date Apr 20, 2026→Mar 9, 2027
    Primary completion May 15, 2026→Jul 9, 2027
    Study completion Jul 15, 2026→Jul 9, 2027
    Primary outcomes 1 time frame changed
    What changed in the outcomes
    • Time frameCancer Protection Motivation Scale (CPMS)3 weeks → Baseline and 1 month after the intervention
    Secondary outcomes 2 time frame changed
    What changed in the outcomes
    • Time frameKnowledge of Cancer and Screening (Structured Questionnaire Score)3 weeks → Baseline and 1 month after the intervention
    • Time frameother outcomeCancer Screening Behavior (Referral and Attendance Rates)3 weeks → Up to 1 month after the intervention
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07541105
Lead sponsor
Toros University
Responsible party
Neslihan Özcanarslan (Doçent, Toros University) — Principal investigator
First posted
Apr 21, 2026
Start date
Mar 9, 2027 (estimated)
Primary completion
Jul 9, 2027 (estimated)
Completion
Jul 9, 2027 (estimated)
Last update
Oct 15, 2026

Study contacts

Neslihan ÖZCANARSLAN, Phd
Contact
neslihan.ozcanarslan@toros.edu.tr
+905336671604

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion